• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK MITEK ACL IMPLANTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK MITEK ACL IMPLANTS Back to Search Results
Catalog Number UNK INTRAFIX
Device Problem Unknown (for use when the device problem is not known) (2204)
Patient Problem Surgical procedure, repeated (2042)
Event Type  Injury  
Event Description
Author: oh (2010) australia.Reference: oh hl, chen db, seeto bg, macdessi sj.Mycobacterium fortuitum infection after anterior cruciate ligament reconstruction using a polylactic acid bioabsorbable screw: case report.Knee.2010 mar;17(2):176-8.Address: sydney knee specialists, suite 211, 203-233 new south head road, edgecliff, nsw 2027, australia tel.: +61 2 8307 0333; fax: +61 2 8307 0334.E-mail address: samuelmacdessi@sydneyknee.Com.Au (s.J.Macdessi).Patient characteristics: age: (b)(6); gender: female; index operation: arthroscopic four-strand autologous hamstring aclr and medial meniscal repair; devices: endobutton + bio-intrafix; time of complication: 11 wks.(travel to (b)(6)); type of complication: mycobacterium fortuitum.Joint: knee, device: bio-intrafix, suture: - na, other devices: - na.Signs and symptoms: 10 mm area of dehiscence in tibial wound with yellow exudates (erythrocyte sedimentation rate (esr) and c-reactive protein normal) no signs of deep infection, no knee joint effusion, range of motion 5° to 90° tissue damage: imaging studies: mri (4 mo.): diffuse soft tissue swelling and fluid collection around the tibial screw and tunnel (normal post-operative high intra-substance signal and intact medial meniscus.Reoperation (related/unrelated): (1) wound debridement, no apparent communication with the tibial tunnel, (2) removal of bio-intrafix screw and sheath, application of v.A.C.Dressing (presence of wide sinus tract from the tibial wound to the tunnel, clear fluid around the implant) (unrelated) medical treatment: oral cephalexin, changed to amoxicillin with clavulanic acid (added roxithromycin later), switched to linezolid (10 wks.) and moxifloxacin (6 mo.) after second operation and mycobacterium testing.F/u time: 7 mo.Imaging studies: na.Objective outcomes: full range of knee movement.Stability (negative lachman¿s test, negative pivot shift test).Functional outcomes: return to pivoting sports.Subjective outcomes: no remaining knee symptoms.
 
Manufacturer Narrative
Mitek medical safety department discovered this published white paper detailing a historical event in which some mitek devices were implicated.It cannot be confirmed that this issue had been previously reported to mitek, so an adverse event report is being filed to document the experience described in the article.At this point in time, no further action is warranted.However, this file will remain receptive to any potential forthcoming information received that is pertinent and germane to this issue.Mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITEK ACL IMPLANTS
Type of Device
ACL IMPLANTS
Manufacturer (Section D)
DEPUY MITEK
325 paramount drive
quality department
raynham MA 02767
Manufacturer (Section G)
DEPUY MITEK
325 paramount drive
na
raynham MA 02767
Manufacturer Contact
siri belur
325 paramount drive
quality department
raynham, MA 02767
8003824682
MDR Report Key3759966
MDR Text Key4485688
Report Number1221934-2014-00144
Device Sequence Number1
Product Code HTY
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 01/31/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK INTRAFIX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date01/31/2014
Event Location Hospital
Initial Date Manufacturer Received 01/31/2014
Initial Date FDA Received04/18/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age15 YR
-
-